TiGenix
id:
tigenix-222-65652
title:
TiGenix
text:
TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell (eASC) platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Its corporate headquarters are in Leuven, Belgium, and it has operations in Madrid, Spain. TiGenix was founded in 2000 by Prof. Dr. Frank P. Luyten and Gil Beyen as a spin-off from the Katholieke Universiteit Leuven and the Ghent University. TiGenix's therapeutic ap
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/TiGenix
date created:
2008-08-28T10:12:36Z
date modified:
2024-09-13T23:30:06Z
main entity:
{"identifier":"Q5363480","url":"https://www.wikidata.org/entity/Q5363480"}
image:
fields total:
13
integrity:
14